ARTICLE | Clinical News
ThGRF 1-44: Began Phase II testing
October 23, 2000 7:00 AM UTC
Theratechnologies Inc. (TSE:TH), Saint Laurent, Quebec Product: ThGRF 1-44 Business: Metabolic Therapeutic category: Hormone replacement Target: Growth hormone secretion Description: Growth hormone r...